Global pharmaceutical company Allergan has announced key future growth drivers for its medical aesthetics portfolio at its first ever Medical Aesthetics Analyst Day this month.
A new report on the regulation of cosmetic treatments in the UK has been released urging the Department of Health and Social Care (DHSC) to introduce legislation that requires mandatory licensing of all cosmetic treatments.
Aesthetic training provider Cosmetic Courses is introducing a new Level 7 Diploma in Clinical Aesthetic Injectable Treatments.
International pharmaceutical company Galderma has expanded the Galderma Aesthetics Academy Faculty with more key opinion leaders joining the team. The Faculty will also be refining a series of masterclasses with a focus on treatment selection for both the full face and individual features, like the lips.
Global pharmaceutical company Allergan Aesthetics has launched HArmonyCa to the UK market, a hybrid injectable treatment combining hyaluronic acid (HA) and calcium hydroxyapatite (CaHA).
A study conducted by the Department of Dermatology at the Feinberg School of Medicine, Northwestern University, has suggested that cannulas are less likely to cause a vascular occlusion than needles when injecting filler.
New technology will be in place from January 31 to monitor advertisements on social media relating to the promotion of prescription-only medicines (POMs) such as botulinum toxin.
The All Party Parliamentary Group on Beauty, Aesthetics and Wellbeing (APPG) has published its final report into botulinum toxin, dermal fillers and other aesthetic non-surgical cosmetic treatments today.
A new marketing study has indicated a high level of patient satisfaction following lip enhancements.
Pharmaceutical company Sinclair Pharma has launched a new bio-stimulating dermal filler for the body.